← Insider buys

Patrick R. Gruber bought GEVO once, on Aug 16, 2018

Director at Gevo, Inc.

SEC CIK 0001511369 · Filings on SEC.gov ↗

$29KBought
$2.5MSold
Aug 16Last buy

Patrick R. Gruber's record

3 months after each buy, from the first price a copier could get.

No buys have 3 months of prices yet. A record shows here at 3.

Every filing

10 filings since Aug 2018, newest first

About Patrick R. Gruber

Dr. Patrick R. Gruber is a corporate insider and longtime leader at Gevo, Inc. (GEVO), where he has served on the board since 2007 and held senior leadership roles including Chief Executive Officer and, following his 2026 retirement from the CEO position, Executive Chair of the Board.( He has been a key architect of Gevo’s strategy to develop and commercialize low‑carbon renewable jet fuel, gasoline, and diesel and other renewable hydrocarbon fuels as alternatives to petrochemical-based products.( In addition to his role at Gevo, he has served as a director at the Biotechnology Innovation Organization and previously sat on the boards of Segetis, Inc., Green Harvest Technologies LLC, and Outlast Technologies.(

Gruber is recognized as a pioneer in industrial biotechnology and green chemistry, with over three decades of experience developing renewable, bio-based technologies to replace petrochemicals.( Before joining Gevo, he was President and CEO of Outlast Technologies (2005–2007) and co‑founded NatureWorks LLC (formerly Cargill Dow), where he served as Vice President, Technology and Operations, and Chief Technology Officer and led the development and commercialization of polylactic acid (PLA) bioplastics.( He began his career at Cargill, working for 16 years on biotechnology projects focused on plant-based materials and fuels.( Gruber holds a Ph.D. in chemistry from the University of Minnesota, an M.B.A. from the Carlson School of Management, and an undergraduate degree from the University of St. Thomas.( His contributions have been recognized with honors including the University of Minnesota Outstanding Achievement Award and the inaugural George Washington Carver Award for achievements in industrial biotechnology.(

Written by Perplexity from public sources.

Filings come from SEC EDGAR. Not investment advice.